Praxis Precision Medicines (PRAX) Misses Q1 EPS by 284c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($2.84). Revenue for the quarter came in at $430 thousand.

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Qualcomm expects $40bn in non-handset revenue by fiscal 2029
• Nomura/Instinet Resumes Toyota Tsusho Corp (8015:JP) at Buy